<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00597311</url>
  </required_header>
  <id_info>
    <org_study_id>BE-2-48</org_study_id>
    <secondary_id>137/2006</secondary_id>
    <nct_id>NCT00597311</nct_id>
  </id_info>
  <brief_title>Preoperative Chemoradiation Versus Short Term Radiation Alone With Delayed Surgery for Stage II and III Resectable Rectal Cancer</brief_title>
  <official_title>Preoperative Chemoradiation Versus Short Term Radiation Alone With Delayed Surgery for Stage II and III Resectable Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaunas University of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaunas University of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Trial compares two preoperative stage II and III rectal cancer treatment strategies: short
      term radiotherapy 5x5 Gy and delayed surgery after 6 weeks versus conventional
      chemoradiotherapy 50 Gy + 5Fu/Lv and surgery also after 6 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2007</start_date>
  <completion_date type="Anticipated">January 2012</completion_date>
  <primary_completion_date type="Anticipated">January 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>5 years overall and disease free survival</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>recurrence rate</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pathological &quot;complete response&quot; and downstaging rates</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact on sphincter sparing operation rates</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>morbidity and mortality rates</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact on quality of surgical resection</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Primary Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>preoperative short term radiation group 5x5 Gy and surgery after 6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>preoperative chemoradiotherapy group 50Gy + 5FU/Lv and surgery after 6 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiotherapy</intervention_name>
    <description>Short term radiotherapy 5x5 Gy during 5 days
Chemoradiotherapy 50 Gy + 5Fu/Lv</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  histologically confirmed stage II and III rectal cancer less than 15 cm from anal
             verge

          -  less than 80 years old

          -  no other cancer during 5 years period

          -  compensate cardiovascular, pulmonary, hepatic and renal functions.

        Exclusion Criteria:

          -  stage I or IV rectal cancer

          -  other cancer in 5 years period

          -  radiotherapy or chemotherapy in anamnesis

          -  not compensate cardiovascular, pulmonary, hepatic or renal functions, neurological,
             psychiatric disease, sepsis, etc.

          -  pregnancy or baby feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dainius Pavalkis, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaunas Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tadas Latkauskas</last_name>
    <phone>+370 676 08901</phone>
    <email>tadas.latkauskas@kmuk.lt</email>
  </overall_contact>
  <location>
    <facility>
      <name>KMUH, surgery department</name>
      <address>
        <city>Kaunas</city>
        <zip>LT3000</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tadas Latkauskas</last_name>
      <phone>+370 676 08901</phone>
      <email>tadas.latkauskas@kmuk.lt</email>
    </contact>
  </location>
  <location_countries>
    <country>Lithuania</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2008</study_first_submitted>
  <study_first_submitted_qc>January 9, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2008</study_first_posted>
  <last_update_submitted>January 9, 2008</last_update_submitted>
  <last_update_submitted_qc>January 9, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2008</last_update_posted>
  <responsible_party>
    <name_title>Tadas Latkauskas</name_title>
    <organization>Kaunas University of Medicine</organization>
  </responsible_party>
  <keyword>rectal cancer</keyword>
  <keyword>radiotherapy</keyword>
  <keyword>radiochemotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

